Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
TOSYMRA (SUMATRIPTAN) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
TOSYMRA
NDA
Get alerts
SUMATRIPTAN | N210884 | TONIX MEDICINES INC
1 strength
9 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Price Trends
Medicare D
DMF
Approvals
Label
Products
Patent Timeline
9 unique patents by expiration date
Expired (3)
Active (6)
Today
2027
2028
2029
2030
2031
Today
8268791
May. 9, 2026
8440631
May. 9, 2026
9211282
Jul. 19, 2031
9283280
May. 9, 2026
9610280
Jun. 16, 2030
9974770
Jun. 16, 2030
10603305
Jun. 16, 2030
11337962
Jun. 16, 2030
12090139
Jun. 16, 2030
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 10MG/SPRAY
RLD
9 patents
0 exclusivities
▴
SPRAY;NASAL | Approved: Jan 25, 2019
Patents (9)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8268791
May 9, 2026
—
—
Yes
—
—
8440631
May 9, 2026
—
—
Yes
U-1719
ACUTE TREATMENT OF MIGRAINE
—
9211282
Jul 19, 2031
—
—
Yes
U-1719
ACUTE TREATMENT OF MIGRAINE
—
9283280
May 9, 2026
—
—
Yes
—
—
9610280
Jun 16, 2030
—
—
Yes
U-1719
ACUTE TREATMENT OF MIGRAINE
—
9974770
Jun 16, 2030
—
—
Yes
U-1719
ACUTE TREATMENT OF MIGRAINE
—
10603305
Jun 16, 2030
—
—
Yes
U-1719
ACUTE TREATMENT OF MIGRAINE
—
11337962
Jun 16, 2030
—
—
Yes
U-1719
ACUTE TREATMENT OF MIGRAINE
—
12090139
Jun 16, 2030
—
—
Yes
—
—